- AuthorisedTherapeutic confirmatory (Phase III)
A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Azetukalner in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)
This study is looking for people with bipolar depression aged 18 or over. It's testing a new medicine, Azetukalner, against a dummy treatment, to see if it helps improve mood over six weeks. The main goal is to check how much depression symptoms change.
For: Depressive episodes associated with Bipolar disorder I or II (Bipolar Depression)Germany · Bulgaria · Spain - AuthorisedTherapeutic confirmatory (Phase III)
A Multicenter, Long-term, Open-Label, Safety, Tolerability, and Efficacy Study of Azetukalner in Bipolar I or II Depression
This study is looking at a new medicine called Azetukalner for people with depression related to bipolar disorder. We want to see how safe and effective it is over a long time, and if it helps improve mood and daily life.
For: Depressive episodes associated with Bipolar disorder I or II (Bipolar Depression)Bulgaria · Germany · France